GO29665
ET16000091
Descriptif de l'étude :
GO29665 A PHASE I/II, MULTICENTER, OPEN-LABEL, DOSE ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF COBIMETINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH PREVIOUSLY TREATED SOLID TUMORS
Promoteur : ROCHE
Lien de l'étude : Clinicalstrials.gov